BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11856504)

  • 61. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparison of two methods for the detection of hepatitis B virus (HBV) DNA in serum samples].
    Jiang SW; Hu AR; Zhou WH; Ying H; Ding SX; Weng PJ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):952-3. PubMed ID: 20038344
    [No Abstract]   [Full Text] [Related]  

  • 63. [HBV markers in severe hepatitis B].
    Fan X; Ren P; Weng S; Hu G
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):391-2. PubMed ID: 11189403
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlation between hepatitis B virus DNA levels and diagnostic tests for HBsAg, HBeAg, and PreS1-Ag in chronic hepatitis B.
    Liu X; Chen JM; Lou JL; Huang YX; Yan Y; Sun GZ; Li N
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421011
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers.
    Noppornpanth S; Sathirapongsasuti N; Chongsrisawat V; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):419-21. PubMed ID: 11127351
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee.
    Pancholi P; Lee DH; Liu Q; Tackney C; Taylor P; Perkus M; Andrus L; Brotman B; Prince AM
    Hepatology; 2001 Feb; 33(2):448-54. PubMed ID: 11172348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular and serological assessment of chronic HBV carriers and additional burden of applying updated guidelines in Pakistan.
    Hussain AB; Ahmed SA; Khan FA; Ghani E; Rathore MA; Ali N
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):620-3. PubMed ID: 25233962
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The relationship of serum HBsAg, HBeAg concentration and HBV-DNA load in chronic hepatitis B during IFN treatment].
    Li MH; Xie Y; Qiu GH; Lu Y; Zhao H; Yang M; Son SJ; Liu F; Zhang SF; Chen LJ; Cheng J; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Feb; 25(1):26-8. PubMed ID: 21789848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biochemical, virological, immunological and histopathological features of 702 incidentally detected chronic hepatitis B virus carriers in Bangladesh.
    Al-Mahtab M; Akbar SM; Rahman S; Kamal M; Khan MS
    Digestion; 2012; 86(1):1-5. PubMed ID: 22688441
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatitis B surface antigen, e antigen and HBV DNA in healthy antenatal patients attending Goroka Hospital and their relationship to tattooing practices.
    Spooner V; Richens J; Sanders R
    P N G Med J; 1990 Mar; 33(1):11-5. PubMed ID: 2346045
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection of serum hepatitis B virus using a nested polymerase chain reaction assay.
    Lucotte G; Galzot P; Lu CY; Bathelier C; Champenois T
    Mol Cell Probes; 1994 Dec; 8(6):437-40. PubMed ID: 7700263
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Association between IgG antibody against the C-terminal region of the preS1 protein of hepatitis B virus and the early response to interferon therapy in chronic hepatitis B].
    Xia GM; Zhang ZH; Wei SF; Gao YF; Zhang TT; Zhang L; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):1-4. PubMed ID: 20128959
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparative analysis of hepatitis B virus large protein, hepatitis B virus-DNA and Pre-S1 antigen in evaluating serum hepatitis B virus replication].
    Xia F; Xu YH; Zheng MJ; Wang XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):501-505. PubMed ID: 28592093
    [No Abstract]   [Full Text] [Related]  

  • 74. [Comparison of liver pathohistological and clinical characteristics between chronic HBV carriers and chronic hepatitis B patients with mild elevation in ALT].
    Geng XX; Lin JM; Yang XX; Huang RG; Jiang N
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):735-9. PubMed ID: 19874687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of HBV DNA and liver histopathology in HBsAg carriers.
    Agalar C; Diri C; Usubütün S; Agalar F; Türkyïlmaz R
    Hepatogastroenterology; 1997; 44(16):1196-9. PubMed ID: 9261624
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Serum hepatitis B markers: atypical patterns detected at the Hospital Insular de Gran Canaria].
    Santana OE; Francés A; Sierra A; Hernández J; Martín-Sánchez AM
    Rev Clin Esp; 1995 Oct; 195(10):674-7. PubMed ID: 8532922
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of hepatitis B virus DNA in HBsAg chronic carriers using a liquid phase molecular hybridization (Abbott HBV DNA) and the DNA polymerase assay: comparison of results.
    Cornu C
    Acta Virol; 1993 Feb; 37(1):84-92. PubMed ID: 7692713
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Dynamics of hepatitis B virus covalently closed circular DNA after serum virology response].
    Li FF; Ren WH; Ding GH; Shi J; Han GQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):167-70. PubMed ID: 19335976
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical research of the relation of hepatitis B surface antigen (HBsAg) quantification and hepatic tissue pathological staging].
    Yu XL; Guo JC; Xun YH; Shi WZ; Wang YF; Wang WW; Liu W
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):44-6. PubMed ID: 23855129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The relationship between HBV-DNA level and histology in patients with naive chronic HBV infection.
    Vardar R; Gunsar F; Sertoz R; Ozacar T; Nart D; Barbet FY; Karasu Z; Ersoz G; Akarca US
    Hepatogastroenterology; 2010; 57(101):908-12. PubMed ID: 21033250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.